Clinical Trials Browser

Phase 2 × Lymphoma × avatrombopag × Clear all

NCT04797182 2021-03-15

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Phase 2 Unknown

Classical hematologyLymphoid

Lymphoma, Thrombocytopenia